| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/08860220600843839 |
| P698 | PubMed publication ID | 17050242 |
| P2093 | author name string | Ganesan Ramesh | |
| W Brian Reeves | |||
| P2860 | cites work | Activation of mitogen-activated protein kinase p38 and extracellular signal-regulated kinase is involved in glass fiber-induced tumor necrosis factor-alpha production in macrophages | Q23914084 |
| Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin | Q24323168 | ||
| Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs | Q24539187 | ||
| Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability | Q28508664 | ||
| MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels | Q28586348 | ||
| AU-rich elements: characterization and importance in mRNA degradation | Q29547896 | ||
| Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators | Q29619837 | ||
| Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats | Q30311216 | ||
| TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway | Q31858969 | ||
| Ubiquitin-dependent mechanism regulates rapid turnover of AU-rich cytokine mRNAs | Q34011276 | ||
| Pharmacological inhibitors of MAPK pathways. | Q34502720 | ||
| Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity | Q34690068 | ||
| p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts | Q34811464 | ||
| Visibly stressed: the role of eIF2, TIA-1, and stress granules in protein translation | Q34966188 | ||
| Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells | Q35940937 | ||
| Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes | Q39696497 | ||
| TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity | Q39738416 | ||
| Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp | Q40018125 | ||
| Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. | Q40019878 | ||
| p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. | Q40460320 | ||
| Cisplatin inactivation of caspases inhibits death ligand-induced cell death in vitro and fulminant liver damage in mice. | Q40474376 | ||
| Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways | Q40657611 | ||
| Lipopolysaccharide stimulation of ERK1/2 increases TNF-alpha production via Egr-1. | Q40733506 | ||
| Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade | Q40848834 | ||
| Requirement for ERK activation in cisplatin-induced apoptosis | Q40854460 | ||
| Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin | Q40859019 | ||
| Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA. | Q40980265 | ||
| Mapping of a minimal AU-rich sequence required for lipopolysaccharide-induced binding of a 55-kDa protein on tumor necrosis factor-alpha mRNA. | Q41037570 | ||
| Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha | Q41039420 | ||
| Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors | Q41099730 | ||
| TIA-1 regulates the production of tumor necrosis factor alpha in macrophages, but not in lymphocytes | Q43837384 | ||
| Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles | Q44066764 | ||
| Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death | Q44242746 | ||
| Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase | Q44285448 | ||
| Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis | Q44486194 | ||
| Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha. | Q44724740 | ||
| TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice. | Q52014017 | ||
| Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. | Q53559996 | ||
| Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. | Q53669925 | ||
| Affinity purification of ARE-binding proteins identifies poly(A)-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization | Q57243671 | ||
| Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury | Q58376211 | ||
| P433 | issue | 7 | |
| P921 | main subject | cisplatin | Q412415 |
| TNF | Q18032037 | ||
| P304 | page(s) | 583-592 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Renal Failure | Q15762963 |
| P1476 | title | Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells. | |
| P478 | volume | 28 |
| Q36906569 | A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity |
| Q60302298 | Distinct patterns of transcriptional and epigenetic alterations characterize acute and chronic kidney injury |
| Q40170223 | Flucytosine and Amphotericin B Coadministration Induces Dose-Related Renal Injury. |
| Q90086485 | INNATE IMMUNITY IN NEPHROTOXIC ACUTE KIDNEY INJURY |
| Q39829228 | Inhibition of p38-MAPK potentiates cisplatin-induced apoptosis via GSH depletion and increases intracellular drug accumulation in growth-arrested kidney tubular epithelial cells |
| Q55447366 | Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT. |
| Q34278172 | Long-term aerobic exercise protects against cisplatin-induced nephrotoxicity by modulating the expression of IL-6 and HO-1. |
| Q64098643 | Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity |
| Q64235559 | Oxaliplatin Treatment Alters Systemic Immune Responses |
| Q34501919 | P2X7 receptors mediate deleterious renal epithelial-fibroblast cross talk |
| Q54522113 | Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity. |
| Q61818125 | Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity |
| Q48124030 | Raloxifene Inhibits NF-kB Pathway and Potentiates Anti-Tumour Activity of Cisplatin with Simultaneous Reduction in its Nephrotoxictiy. |
| Q27310345 | Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-α gene in acute kidney injury |
| Q36662114 | TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity |
| Q61795768 | The Effect of Arabic Gum on Renal Function in Reversible Unilateral Ureteric Obstruction |
| Q37302978 | Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin |
| Q80540729 | Tumor necrosis factor-alpha in cisplatin nephrotoxicity: a homebred foe? |
| Q36836229 | Tumor necrosis factor-α: regulation of renal function and blood pressure |
Search more.